These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7898711)

  • 41. Neurocysticercosis.
    Mukherjee A; Roy T; Mukherjee S; Basu N; Duttamunshi A
    J Assoc Physicians India; 1993 May; 41(5):287-9. PubMed ID: 8300463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cerebral cysticercosis].
    Hagelskjaer LH; Hansen NJ; Christensen T
    Ugeskr Laeger; 1991 Sep; 153(39):2754-5. PubMed ID: 1949294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.
    Hofmann B; Bass H; Nishanian P; Faisal M; Figlin RA; Sarna GP; Fahey JL
    Clin Exp Immunol; 1992 Jun; 88(3):548-54. PubMed ID: 1606739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cerebral cysticercosis. Apropos of a case treated with praziquantel].
    Leger J; Bruguier A; Texier P; Diebler C; Ponsot G
    Arch Fr Pediatr; 1985; 42(6):451-3. PubMed ID: 4051677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Praziquantel therapy in childhood neurocysticercosis.
    Kalra V; Deorari AK; Goulatia RK
    Indian Pediatr; 1987 Dec; 24(12):1095-8. PubMed ID: 3450660
    [No Abstract]   [Full Text] [Related]  

  • 46. Cerebrospinal fluid neopterin levels in 159 neurologically asymptomatic persons infected with the human immunodeficiency virus (HIV-1): relationship to immune status.
    Lucey DR; McGuire SA; Abbadessa S; Hall K; Woolford B; Valtier S; Butzin CA; Melcher GP; Hendrix CW
    Viral Immunol; 1993; 6(4):267-72. PubMed ID: 7909441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Grand-mal epilepsy as initial manifestation of a parenchymal neuro_cysticercosis].
    Rowedder A; Schafroth E; Schlup P
    Schweiz Med Wochenschr; 1993 Jan; 123(4):125-9. PubMed ID: 8426958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis].
    Cohen L; Belec L; Sanson M; Pierrot-Deseilligny C; Signoret JL
    Rev Neurol (Paris); 1992; 148(1):58-61. PubMed ID: 1604116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrospinal fluid and serum neopterin levels in patients with Lyme neuroborreliosis.
    Dotevall L; Fuchs D; Reibnegger G; Wachter H; Hagberg L
    Infection; 1990; 18(4):210-4. PubMed ID: 2210852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrathecal synthesis of specific immunoglobulin G antibodies in neurocysticercosis: evaluation of antibody concentrations by enzyme-linked immunosorbent assay using a whole cysticercal extract and cyst vesicular fluid as antigens.
    Arruda GC; Quagliato EM; Rossi CL
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):45-9. PubMed ID: 16290026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurocysticercosis in Brazilian children: report of 10 cases.
    Ferreira MS; Costa-Cruz JM; Nishioka SA; Mantese OC; Castro E; Gonçalves-Pires MR; Moura LP
    Trop Med Parasitol; 1994 Mar; 45(1):49-50. PubMed ID: 8066383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subcutaneous and cerebral cysticercosis treated with praziquantel.
    Quimosing EM; Conde J; Cross JH
    Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):201-5. PubMed ID: 6505787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Neurocysticercosis. Treatment with praziquantel. A preliminary study (author's transl)].
    Brink G; Schenone H; Díaz V; Parra M; Corrales M
    Bol Chil Parasitol; 1980; 35(3-4):66-70. PubMed ID: 7317137
    [No Abstract]   [Full Text] [Related]  

  • 54. Unusual complication in a patient with renal transplantation: cerebral cysticercosis.
    Gordillo-Paniagua G; Muñoz-Arizpe R; Ponsa-Molina R
    Nephron; 1987; 45(1):65-7. PubMed ID: 3543710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Surgery in cases of neurocysticercosis treated with praziquantel].
    Vargas Tentori N
    Salud Publica Mex; 1982; 24(6):661-77. PubMed ID: 7185173
    [No Abstract]   [Full Text] [Related]  

  • 56. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.
    Schürmann G; Betzler M; Post S; Herfarth C; Meuer S
    Digestion; 1992; 51(1):51-9. PubMed ID: 1639222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Problems in neurocysticercosis after praziquantel therapy.
    Parikh PM; Anjaria PD; Chile VS
    J Assoc Physicians India; 1988 Oct; 36(10):620-1. PubMed ID: 3220813
    [No Abstract]   [Full Text] [Related]  

  • 58. Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus.
    Gilad R; Lampl Y; Eshel Y; Barak V; Sarova-Pinhas I
    Br J Rheumatol; 1997 Feb; 36(2):190-3. PubMed ID: 9133927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Integrity of the blood-brain barrier and intrathecal synthesis of IgG in parenchymatous and subarachnoid cerebral cysticercosis].
    Estañol Vidal B; Díaz Granados J; Corona Vázquez T
    Rev Invest Clin; 1989; 41(4):327-30. PubMed ID: 2631167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Neurocysticercosis].
    Bauer TM; Brühwiler J; Aschwanden M; Wagner S; Schwander J
    Dtsch Med Wochenschr; 1994 Feb; 119(6):175-9. PubMed ID: 8306852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.